Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside

Summary: Sell-side estimates for this quarter's revenue are too high and have begun to be cut.The guidance of 110m in...

wpadmin
July 15, 2019